Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome.
Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Thoracic sensory level as a false localizing sign in cervical spinal cord and brain lesions.
Shifting paradigms in multiple sclerosis: from disease-specific, through population-specific toward patient-specific.
Successful cyclosporine treatment in 2 patients with refractory CIDP, involving monitoring of both AUC(0-4h) and trough levels.
Alterations in hippocampal myelin and oligodendrocyte precursor cells during epileptogenesis.
Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
Polymorphisms of Immunoglobulin G Fc Receptors in Pediatric Guillain-Barré Syndrome.
Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases.
Cavernous angioma: a clinical study of 35 cases with review of the literature.
Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation.
Intracellular and circulating neuronal antinuclear antibodies in human epilepsy.
Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.
Splenic Marginal Zone Lymphoma: An indolent malignancy leading to the development of neurolymphomatosis.
Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls.
Emerging Role of P2X7 Receptors in CNS Health and Disease.
Is It worth Considering Circulating microRNAs in Multiple Sclerosis?
Osmotic demyelination syndrome complicating diabetes with anti-glutamic acid decarboxylase antibodies and Graves' disease: A case report.
Key players in neurodegenerative disorders in focus - new insights into the proteomic profile of Alzheimer`s disease, schizophrenia, ALS and multiple sclerosis - 24th HUPO BPP Workshop: 29 September 2015, Vancouver, Canada.
The effects of early maternal deprivation on auditory information processing in adult Wistar rats.
GENETIC POLYMORPHISMS OF HUMAN β-DEFENSINS IN PATIENTS WITH MULTIPLE SCLEROSIS.
Impaired oligodendrocyte maturation in preterm infants: Potential therapeutic targets.
Perioperative management of a patient undergoing a novel mini-invasive percutaneous transcatheter left ventricular reconstruction procedure.
Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
Pages
« first
‹ previous
…
722
723
724
725
726
727
728
729
730
…
next ›
last »